71 related articles for article (PubMed ID: 23929688)
1. Novel γ-sarcoglycan-mutation affects cardiac function and N-terminal dystrophin expression.
Schröder NW; Grieben U; Prokop S; Dekomien G; Epplen JT; Heppner FL; Goebel HH; Stenzel W
Muscle Nerve; 2014 Jan; 49(1):144-5. PubMed ID: 23929688
[No Abstract] [Full Text] [Related]
2. A 5' dystrophin duplication mutation causes membrane deficiency of alpha-dystroglycan in a family with X-linked cardiomyopathy.
Bies RD; Maeda M; Roberds SL; Holder E; Bohlmeyer T; Young JB; Campbell KP
J Mol Cell Cardiol; 1997 Dec; 29(12):3175-88. PubMed ID: 9441825
[TBL] [Abstract][Full Text] [Related]
3. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy.
Franz WM; Müller M; Müller OJ; Herrmann R; Rothmann T; Cremer M; Cohn RD; Voit T; Katus HA
Lancet; 2000 May; 355(9217):1781-5. PubMed ID: 10832829
[TBL] [Abstract][Full Text] [Related]
4. Novel mutation in splicing donor of dystrophin gene first exon in a patient with dilated cardiomyopathy but no clinical signs of skeletal myopathy.
Kimura S; Ikezawa M; Ozasa S; Ito K; Ueno H; Yoshioka K; Ijiri S; Nomura K; Nakamura K; Matuskura M; Miike T
J Child Neurol; 2007 Jul; 22(7):901-6. PubMed ID: 17715288
[TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy mutations in δ-sarcoglycan exert a dominant-negative effect on cardiac myocyte mechanical stability.
Campbell MD; Witcher M; Gopal A; Michele DE
Am J Physiol Heart Circ Physiol; 2016 May; 310(9):H1140-50. PubMed ID: 26968544
[TBL] [Abstract][Full Text] [Related]
6. Sarcoglycans in muscular dystrophy.
Hack AA; Groh ME; McNally EM
Microsc Res Tech; 2000 Feb 1-15; 48(3-4):167-80. PubMed ID: 10679964
[TBL] [Abstract][Full Text] [Related]
7. [Mutations of the dystrophin gene in dilated cardiomyopathy].
Shiga N; Akita H; Yokoyama M
Nihon Rinsho; 2000 Jan; 58(1):123-7. PubMed ID: 10885299
[TBL] [Abstract][Full Text] [Related]
8. Consequences of disrupting the dystrophin-sarcoglycan complex in cardiac and skeletal myopathy.
Heydemann A; McNally EM
Trends Cardiovasc Med; 2007 Feb; 17(2):55-9. PubMed ID: 17292047
[TBL] [Abstract][Full Text] [Related]
9. Identification of functional domains in sarcoglycans essential for their interaction and plasma membrane targeting.
Chen J; Shi W; Zhang Y; Sokol R; Cai H; Lun M; Moore BF; Farber MJ; Stepanchick JS; Bönnemann CG; Chan YM
Exp Cell Res; 2006 May; 312(9):1610-25. PubMed ID: 16524571
[TBL] [Abstract][Full Text] [Related]
10. Multiple pathogenetic mechanisms in X linked dilated cardiomyopathy.
Cohen N; Muntoni F
Heart; 2004 Aug; 90(8):835-41. PubMed ID: 15253946
[TBL] [Abstract][Full Text] [Related]
11. Does delta-sarcoglycan-associated autosomal-dominant cardiomyopathy exist?
Bauer R; Hudson J; Müller HD; Sommer C; Dekomien G; Bourke J; Routledge D; Bushby K; Klepper J; Straub V
Eur J Hum Genet; 2009 Sep; 17(9):1148-53. PubMed ID: 19259135
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sarcoglycans, vinculin-talin-integrin system and filamin2 in alpha- and gamma-sarcoglycanopathy: an immunohistochemical study.
Anastasi G; Cutroneo G; Trimarchi F; Santoro G; Bruschetta D; Bramanti P; Pisani A; Favaloro A
Int J Mol Med; 2004 Dec; 14(6):989-99. PubMed ID: 15547664
[TBL] [Abstract][Full Text] [Related]
13. [Gene errors of dilated cardiomyopathy].
Heliö T; Kaartinen M; Kärkkäinen S; Peuhkurinen K
Duodecim; 2001; 117(18):1797-800. PubMed ID: 12181975
[No Abstract] [Full Text] [Related]
14. Follow-up of three patients with a large in-frame deletion of exons 45-55 in the Duchenne muscular dystrophy (DMD) gene.
Nakamura A; Yoshida K; Fukushima K; Ueda H; Urasawa N; Koyama J; Yazaki Y; Yazaki M; Sakai T; Haruta S; Takeda S; Ikeda S
J Clin Neurosci; 2008 Jul; 15(7):757-63. PubMed ID: 18261911
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyopathy is independent of skeletal muscle disease in muscular dystrophy.
Zhu X; Wheeler MT; Hadhazy M; Lam MY; McNally EM
FASEB J; 2002 Jul; 16(9):1096-8. PubMed ID: 12039854
[TBL] [Abstract][Full Text] [Related]
16. The mouse dystrophin muscle enhancer-1 imparts skeletal muscle, but not cardiac muscle, expression onto the dystrophin Purkinje promoter in transgenic mice.
De Repentigny Y; Marshall P; Worton RG; Kothary R
Hum Mol Genet; 2004 Nov; 13(22):2853-62. PubMed ID: 15385445
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.
Tsubata S; Bowles KR; Vatta M; Zintz C; Titus J; Muhonen L; Bowles NE; Towbin JA
J Clin Invest; 2000 Sep; 106(5):655-62. PubMed ID: 10974018
[TBL] [Abstract][Full Text] [Related]
18. Epsilon-sarcoglycan compensates for lack of alpha-sarcoglycan in a mouse model of limb-girdle muscular dystrophy.
Imamura M; Mochizuki Y; Engvall E; Takeda S
Hum Mol Genet; 2005 Mar; 14(6):775-83. PubMed ID: 15689353
[TBL] [Abstract][Full Text] [Related]
19. [Gamma-sarcoglycanopathy: clinico-pathological and genetic study of 11 cases].
García-García D; Teijeira-Bautista S; Fernández-Rodríguez JM; Flores-Calvete J; Sánchez-Espíldora P; Fernández-Couto D; Cimas-Hernando I; Teijeiro-Ferreira A; Fernández-Hojas R; Brasa-Fernández Fierros J; Martínez de Alegría A; Escribano-Arias JL; Núñez-Delgado M; Navarro-Fernández Balbuena C
Rev Neurol; 1998 Jun; 26(154):905-11. PubMed ID: 9658457
[TBL] [Abstract][Full Text] [Related]
20. A novel Alu-like element rearranged in the dystrophin gene causes a splicing mutation in a family with X-linked dilated cardiomyopathy.
Ferlini A; Galié N; Merlini L; Sewry C; Branzi A; Muntoni F
Am J Hum Genet; 1998 Aug; 63(2):436-46. PubMed ID: 9683584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
